Microbot Medical Inc. filed a current report on November 5, 2026, disclosing that the Canadian Intellectual Property Office granted the company a patent covering an adaptor that couples elongate surgical tools to a motorized robotic surgical device.

Key Highlights

  • Canadian patent granted: The Canadian Intellectual Property Office (CIPO) issued a patent to Microbot Medical for an adaptor for coupling a proximal portion of an elongate surgical tool, including guidewires and microcatheters, to a motorized robotic surgical device.
  • Global patent portfolio: As of November 5, 2026, the company disclosed it holds 45 issued patents and 48 patent applications worldwide.
  • North American patents: According to the filing, 21 of those issued patents are held in North America.
  • Disclosure basis: The patent announcement was made under Regulation FD and accompanied by a press release furnished as Exhibit 99.1, dated November 5, 2026.
  • Exchange listing: Microbot Medical common stock, $0.01 par value, trades on NASDAQ:MBOT.

Microbot Medical's Canadian Patent Adds to Growing Robotic Surgical IP Portfolio

Microbot Medical Inc., a Delaware-incorporated medical device company headquartered at 175 Derby St., Bld. 27, Hingham, MA 02043, develops technology in the robotic surgical space. According to the filing, the company's newly granted Canadian patent covers an adaptor designed to couple the proximal portion of elongate surgical tools, specifically guidewires, microcatheters, and similar instruments, to a motorized robotic surgical device. The disclosure was made under Item 7.01, Regulation FD, via a press release furnished as Exhibit 99.1.

The filing also reported, under Item 8.01, that as of November 5, 2026, Microbot Medical holds 45 issued patents and 48 patent applications worldwide, including 21 issued patents in North America. The addition of this Canadian patent is part of that disclosed total. The company noted that the information furnished under Item 7.01, including Exhibit 99.1, "shall not be deemed to be 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934," and that "the Company is making no admission as to the materiality of any information in this Item 7.01 or Exhibit 99.1." The report was signed by Harel Gadot, Chief Executive Officer, President and Chairman.

What Was Disclosed

Microbot Medical disclosed the receipt of a Canadian patent for a robotic surgical adaptor and reported its current global intellectual property portfolio, comprising 45 issued patents and 48 pending applications worldwide as of November 5, 2026, with 21 issued patents in North America.